NanoPhoria is a startup based in the United States, 3 tracked investors.
Based in the United States, NanoPhoria is a startup. Brouky records 3 investors associated with the company.
NanoPhoria Bioscience is a preclinical-stage biotechnology company pioneering next generation cardiovascular treatments through an innovative inhaled Nano-in-Micro delivery platform targeting heart failure with reduced ejection fraction (HFrEF).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.